U.S. markets closed

Encompass Health Corporation (EHC)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
58.69+0.36 (+0.62%)
At close: 04:00PM EST
58.69 0.00 (0.00%)
After hours: 06:03PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Previous Close58.33
Bid58.37 x 1300
Ask58.42 x 1000
Day's Range57.99 - 59.13
52 Week Range56.31 - 89.68
Avg. Volume775,057
Market Cap5.839B
Beta (5Y Monthly)0.99
PE Ratio (TTM)14.45
EPS (TTM)4.06
Earnings DateJan 24, 2022 - Jan 28, 2022
Forward Dividend & Yield1.12 (1.92%)
Ex-Dividend DateDec 31, 2021
1y Target Est85.75
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Near Fair Value
-0% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for EHC

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Encompass Health Corporation
    EHC: Lowering target price to $76.00ENCOMPASS HEALTH CORP has an Investment Rating of BUY; a target price of $76.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
    Fair Value
    Economic Moat
    3 days agoArgus Research
View more